These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4358536)

  • 1. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
    Silagi S; Newcomb EW; Weksler ME
    Cancer Res; 1974 Jan; 34(1):100-4. PubMed ID: 4358536
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
    Silagi S; Calvelli TA
    Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HL-A and other cell-surface antigens on cultured cells by a cytotoxic plating inhibition test.
    Takasugi M; Terasaki PI
    J Natl Cancer Inst; 1972 Nov; 49(5):1229-37. PubMed ID: 4675381
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in cell surface properties during the in vivo growth of Moloney lymphoma.
    Fenyö EM; Peebles PT; Wahlström A; Klein E; Cochran AJ
    Isr J Med Sci; 1973 Mar; 9(3):239-50. PubMed ID: 4575651
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine.
    Silagi S; Balint RF; Gauri KK
    Cancer Res; 1977 Sep; 37(9):3367-73. PubMed ID: 884681
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral expression, oncogenicity, and antigenicity of a mouse salivary gland tumor and two cell lines derived from it.
    Castelli L; Neri G; Frigola A; Di Fava FM; Giuliano MC
    Cancer Res; 1975 Sep; 35(9):2394-402. PubMed ID: 50130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL; Ting RC; Morton DL; Law LW
    J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased immunogenicity of B16 melanoma clones selected for their ability to metastasize from a heterogeneous primary tumor.
    Steele GD; Richie JP; Wang BS; Mannick JA; Wilson RE
    Surg Forum; 1979; 30():132-3. PubMed ID: 538574
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterotransplantation model of human malignant melanoma.
    Mukherji B; Flowers A; Nathanson L; Clark DA
    Cancer Res; 1974 Jan; 34(1):43-6. PubMed ID: 4588548
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protection afforded by hybrid cells against the inoculation of the parental tumour line (author's transl)].
    Favre R; Filipczyk J; Berebbi M; Meyer G
    Ann Immunol (Paris); 1974; 125(3):491-7. PubMed ID: 4369657
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression and oncogenic virus infections.
    Hirsch MS; Black PH; Proffitt MR
    Fed Proc; 1971; 30(6):1852-7. PubMed ID: 4330993
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen fluctuation and virus activation in EL 4 cells transplanted in hybrid mice or cultured in vitro.
    Colnaghi MI; Pierotti MA; Torre GD; Miotti S
    J Natl Cancer Inst; 1977 Jul; 59(1):123-30. PubMed ID: 195063
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of three in vivo assays for cell tumorigenicity.
    Petricciani JC; Wallace RE; McCoy DW
    Cancer Res; 1974 Jan; 34(1):105-8. PubMed ID: 4203458
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological studies of runting syndrome in rats inoculated with Friend virus.
    Takeichi N; Kuzumaki N; Kobayashi H
    Cancer Res; 1973 Dec; 33(12):3096-102. PubMed ID: 4148554
    [No Abstract]   [Full Text] [Related]  

  • 15. Host immune response to virus-induced tumors. Some recent concepts.
    Aoki T; Chieco-Bianchi L; Plata EJ; Sendo F; Hollis VW; Kudo T
    Prog Exp Tumor Res; 1974; 19():23-36. PubMed ID: 4373781
    [No Abstract]   [Full Text] [Related]  

  • 16. Recovery of murine xenotropic type-C virus from C57L mice.
    Arnstein P; Levy JA; Oshiro LS; Price PJ; Suk W; Lennette EH
    J Natl Cancer Inst; 1974 Dec; 53(6):1787-92. PubMed ID: 4140240
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneous disappearance of tumorigenicity in a polyoma virus-induced neoplasm carried in vitro.
    Cohen JM; Law LW
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):385-8. PubMed ID: 4360637
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells.
    Silagi S
    Int Rev Cytol; 1976; 45():65-111. PubMed ID: 821894
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.